Prostate and Urologic Cancer Clinical Trials

Titlesort descending Intervention NCT ID Sponsor Status
PROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer... Laboratory Biomarker Analysis, Placebo, Rilimogene Galvacirepvec NCT02326805 National Cancer Institute (NCI) Active, not recruiting
Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies Placebo, Dutasteride NCT01594502 University of Illinois at Chicago Active, not recruiting